Columbia University, SMA Clinical Research Center

New York, New York 10032

0 studies enrolling now · 4 studies all time

What they study most

Anti-myostatin, Atrophy, Muscular Atrophy, Muscular Atrophy, Spinal, Neuromuscular Disease, Neuromuscular Diseases, Neuromuscular Manifestations, SMA, Spinal Muscular Atrophy, Spinal Muscular Atrophy Type 2, Spinal Muscular Atrophy Type 3

Studies at this site

• Efficacy and Safety of Apitegromab in Patients With Later-Onset Spinal Muscular Atrophy Treated With Nusinersen or Risdiplam — Completed
• Clinical Study of Spinal Muscular Atrophy — Completed
• Clinical Trial of Exercise in Patients With Spinal Muscular Atrophy (SMA) — Completed
• A Pilot Study of Biomarkers for Spinal Muscular Atrophy — Completed